Fabrinet heads into its fiscal fourth-quarter report carrying a strange combination for a company whose growth is accelerating: a stock that has fallen nearly 12% since its last earnings release while the S&P 500 climbed almost 8%. That 20-point gap in relative performance is the central puzzle investors need to resolve, because the operating story management told three months ago was one of the most optimistic in years, even as it came wrapped in a supply-constraint caveat that never fully went away.

Consensus calls for non-GAAP EPS of $3.81 on revenue of $1.28 billion, comfortably within management's guided range of $3.72 to $3.87 per share on $1.25 billion to $1.29 billion in sales. That guidance itself was a raise from the prior quarter's outlook, continuing a pattern of upward revisions that has defined Fabrinet's last several quarters. The Street's revenue estimate sits toward the upper half of that range, implying about 41% year-over-year growth, a bar management set for itself after Q3 revenue already accelerated to 39% growth. The Earnings Whisper number of $3.87 sits at the very top of guidance, suggesting some expectation of another beat, though the gap over consensus is modest enough that it shouldn't be read as a dramatic signal either way.

What matters more than the headline numbers is whether the supply-constraint narrative that capped Datacom shipments last quarter is easing or hardening. Management was explicit that demand for Datacom products exceeded what the company could physically ship due to shortages in lasers, memory and certain ASICs, and that this would persist into the current quarter. Datacom revenue actually declined sequentially last quarter for the first time in a while, even as management insisted the shortfall was supply-driven rather than a demand problem. This report needs to show Datacom stabilizing or reaccelerating to validate that framing. If Datacom remains flat or weakens further, investors will start questioning whether the constraint is really temporary.

Telecom, and DCI in particular, has been the real engine of growth, posting 55% and 90% year-over-year gains respectively last quarter. Continued strength there would confirm that Fabrinet's growth story is broadening rather than resting on a single product line. Equally important is evidence on the newer catalysts management introduced last call: the two 800G transceiver programs now shipping directly to a hyperscaler, the merchant transceiver ramps expected in the second half of the calendar year, and progress on the Raytech investment tied to co-packaged optics. These were framed as meaningful for fiscal 2027, so this quarter is unlikely to show dramatic revenue contribution, but commentary on qualification timelines and ramp cadence will tell investors whether those programs are on track.

Margins are the other swing factor. Gross margin slipped to 12.1% last quarter, below the mid-12% target management has cited, pressured by new-program ramp costs and currency effects. Guidance implied margins would stay similar this quarter, so any further erosion would raise concerns that the profitability drag from ramping multiple new programs simultaneously is lasting longer than expected. Free cash flow also turned negative for two consecutive quarters as capital spending on capacity expansion, including the new Nava campus in Thailand and the accelerated Building 10 timeline, ramps up. Investors should watch whether that investment phase shows signs of tapering or whether it continues to weigh on cash generation.

Sentiment heading into this report has turned slightly negative, a shift from the mildly bullish reading before the last release, which lines up with the stock's underperformance. The shares trade above their 200-day moving average near $535 but remain well off the post-earnings high of nearly $749 set earlier this year, leaving plenty of room between the current price and that ceiling. The central question for this report is whether Fabrinet can show that its supply constraints are genuinely temporary and that new program ramps are translating into margin recovery, because without that evidence, the gap between operational optimism and stock performance is likely to persist.